← Leaderboards

Angela D Kashuba

University Of North Carolina Chapel Hill

Google Scholar ↗PubMed ↗ORCID ↗

$21,136,729

Attributed

$23,384,077

Total exposure

22

Grants

19

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY2005–25

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$23,384,077 · 22

By mechanism

R01$9,587,331 · 2

P30$6,787,375 · 4

M01$2,415,612 · 11

U01$2,353,202 · 1

U19$1,108,789 · 1

K23$633,150 · 1

Top collaborators

Elias Rosen5 shared

Most similar at University Of North Carolina Chapel Hill

Same institution · by research overlap

Steven Nmn Offenbacher$19,026,540
Michael W Fried$8,954,521
Gary M Pollack$1,883,076
Carl Bose$7,998,029
Philip C Smith$1,688,141

Others in their field

Top investigators on “Clinical Research”

David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
Sonia M Thomas · Research Triangle Institute$700,865,642
Jeffrey P Krischer · University Of South Florida$611,867,176
Barton F Haynes · Duke University$538,862,577

Research focus

Clinical ResearchResearch PersonnelPharmacologyPharmaceutical PreparationsTissuesCellsClinical TrialsAnti-Retroviral AgentsPlasmaBiologicalResourcesAreaHiv InfectionsDrug DevelopmentBaseDrug ExposureSamplingDesignInternationalClinical PharmacologyAnalytical ChemistryDrug KineticsInstitutionDose

Grant awards (71)

UNC Center for AIDS Research Core E Clinical Pharmacology/Analytical Chemistry$261,178

P30 · FY2025 · AI · contact PI

UNC Center for AIDS Research Core E Clinical Pharmacology/Analytical Chemistry$258,183

P30 · FY2024 · AI · contact PI

UNC Center for AIDS Research Core E Clinical Pharmacology/Analytical Chemistry$307,659

P30 · FY2023 · AI · contact PI

UNC Center for AIDS Research Core E Clinical Pharmacology/Analytical Chemistry$300,423

P30 · FY2022 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$749,632

R01 · FY2021 · AI · contact PI

UNC Center for AIDS Research Core E Clinical Pharmacology/Analytical Chemistry$455,525

P30 · FY2021 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$958,259

R01 · FY2020 · AI · contact PI

UNC Center for AIDS Research Core E Pharmacology$298,824

P30 · FY2020 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$1,009,616

R01 · FY2019 · AI · contact PI

UNC Center for AIDS Research Core E Pharmacology$457,132

P30 · FY2019 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$1,009,409

R01 · FY2018 · AI · contact PI

Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs$728,895

R01 · FY2018 · AI · contact PI

UNC Center for AIDS Research Core E Pharmacology$323,475

P30 · FY2018 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$767,780

R01 · FY2017 · AI · contact PI

Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs$728,895

R01 · FY2017 · AI · contact PI

UNC Center for AIDS Research Core E Pharmacology$317,875

P30 · FY2017 · AI · contact PI

Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs$1,175,010

R01 · FY2016 · AI · contact PI

Novel Mass Spectrometry Imaging Methods to Quantify Antiretroviral Adherence$803,345

R01 · FY2016 · AI · contact PI

UNC Center for AIDS Research Core E Pharmacology$312,751

P30 · FY2016 · AI · contact PI

Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs$848,011

R01 · FY2015 · AI · contact PI

Clinical Pharmacology & Analytical Chemistry Core$295,263

P30 · FY2015 · AI · contact PI

Pharmacology Core$219,836

U19 · FY2015 · AI · contact PI

Multi-Species Mechanisms of Drug Bio-distribution in HIV Tissue Reservoirs$808,479

R01 · FY2014 · AI · contact PI

Clinical Pharmacology & Analytical Chemistry Core$283,439

P30 · FY2014 · AI · contact PI

Pharmacology Core$248,429

U19 · FY2014 · AI · contact PI

Clinical Pharmacology & Analytical Chemistry Core$879,623

P30 · FY2013 · AI · contact PI

Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues$668,820

U01 · FY2013 · AI · contact PI

Pharmacology Core$204,937

U19 · FY2013 · AI · contact PI

Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues$953,109

U01 · FY2012 · AI · contact PI

Clinical Pharmacology & Analytical Chemistry Core$283,319

P30 · FY2012 · AI · contact PI

Pharmacology Core$209,495

U19 · FY2012 · AI · contact PI

Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues$731,273

U01 · FY2011 · AI · contact PI

UPLC-MS/MS to Support Preclinical and Clinical Antiretroviral Pharmacology Studie$387,618

S10 · FY2011 · RR · contact PI

Clinical Pharmacology & Analytical Chemistry Core$292,332

P30 · FY2011 · AI · contact PI

Pharmacology Core$226,092

U19 · FY2011 · AI · contact PI

CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE$363,959

P30 · FY2010 · AI · contact PI

Preventing HIV Infection in Women: Targeting Antiretrovirals to Mucosal Tissues$111,000

R34 · FY2010 · AI · contact PI

CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE$278,041

P30 · FY2009 · AI · contact PI

CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE$298,429

P30 · FY2008 · AI · contact PI

CLINICAL TRIAL: MARAVIROC EXPOSURE IN BLOOD, CERVICOVAGINAL FLUID, VAGINAL TISSU$9,412

M01 · FY2008 · RR · contact PI

CLINICAL TRIAL: EFFECT OF PREGNANCY ON THE PHARMACOKINETICS OF THE KALETRALO$3,035

M01 · FY2008 · RR · contact PI

TIPRANIVIR CAPSULE ON CYP450 AND P-GLYCOPROTEIN IN HEALTHY HUMANS$1,147,187

M01 · FY2007 · RR · contact PI

CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE$266,897

P30 · FY2007 · AI · contact PI

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT$126,630

K23 · FY2007 · AI · contact PI

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT: CAN WE AFFECT HIV TRANSMISSION$28,593

M01 · FY2007 · RR · contact PI

IMPACT OF PREGNANCY ON DISPOSITION OF ANTIRETROVIRAL AGENTS IN BLOOD PLASMA$16,014

M01 · FY2007 · RR · contact PI

CLINICAL PHARMACOLOGY AND ANALYTICAL CHEMISTRY CORE$253,048

P30 · FY2006 · AI · contact PI

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT$126,630

K23 · FY2006 · AI · contact PI

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT: CAN WE AFFECT HIV TRANSMISSION$61,402

M01 · FY2006 · RR · contact PI

IMPACT OF PREGNANCY ON DISPOSITION OF ANTIRETROVIRAL AGENTS IN BLOOD PLASMA$42,278

M01 · FY2006 · RR · contact PI

RATE AND EXTENT OF TENOFOVIR EXPOSURE AND ANTIVIRAL EFFECTS IN GENITAL TRACTS$38,252

M01 · FY2006 · RR · contact PI

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT: CAN WE AFFECT HIV TRANSMISSION$166,458

M01 · FY2005 · RR

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT$126,630

K23 · FY2005 · AI

RATE AND EXTENT OF TENOFOVIR EXPOSURE AND ANTIVIRAL EFFECTS IN GENITAL TRACTS$61,284

M01 · FY2005 · RR

IMPACT OF PREGNANCY ON DISPOSITION OF ANTIRETROVIRAL AGENTS IN BLOOD PLASMA$33,125

M01 · FY2005 · RR

LOPINAVIR/RITONAVIR ON CYTOCHROME P450 - HEALTHY VOLUNTEERS$5,341

M01 · FY2005 · RR

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT$126,630

K23 · FY2004 · AI

Lopinavir/Ritonavir on Cytochrome P450 - Healthy Volunteers$65,944

M01 · FY2004 · RR

Antiretroviral Pharmacology in the Genital Tract: Can We Affect HIV Transmission$60,206

M01 · FY2004 · RR

Compare Female Genital Tract Virology and Pharmacology to HIV-1 Women$791

M01 · FY2004 · RR

ANTIRETROVIRAL PHARMACOLOGY IN THE GENITAL TRACT$126,630

K23 · FY2003 · AI

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$190,747

M01 · FY2002 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$294,555

M01 · FY2001 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$190,747

M01 · FY2001 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$241

M01 · FY2000 · RR

CYTOCHROME P4501A2, CYTOCHROME P450D6, N-ACETYITRANSFERASE-2 &XANTHINE OXIDASE$0

M01 · FY2000 · RR

CYTOCHROME P4501A2, CYTOCHROME P450D6, N-ACETYITRANSFERASE-2 &XANTHINE OXIDASE$0

M01 · FY2000 · RR

CYTOCHROME P4501A2, CYTOCHROME P450D6, N-ACETYITRANSFERASE-2 &XANTHINE OXIDASE$0

M01 · FY2000 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$0

M01 · FY2000 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$0

M01 · FY2000 · RR

CYTOCHROME P450 IA2, IID6, IIIA4, NAT 2 &XANTHINE OXIDASE IN HIV 1$0

M01 · FY2000 · RR